- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05687227
Online Education and Counseling Regarding Gynecological Examination
January 6, 2023 updated by: Belma Toptas Acar, Aydin Adnan Menderes University
The Effect on Women's Attitude and Anxiety Levels Regarding Gynecological Examination of Online Education and Counseling
This research was carried out to determine the effect of online education and counseling on women's attitudes and anxiety levels regarding gynecological examination.
The research is a pre-test-post-test, randomized controlled experimental study.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The research is a pre-test-post-test, randomized controlled experimental study.
Simple randomization method was used to assign the participants to the groups.
The sample consisted of a total of 100 women (experimental group: 50 women and control group: 50 women).
The study was carried out with women who applied to Aydın Adnan Menderes University Application and Research Hospital, Gynecology Clinic, Gynecology Outpatient Clinic and met the study criteria.
Study Type
Interventional
Enrollment (Actual)
100
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Aydın, Turkey, 09010
- Aydın Adnan Menderes University Application and Research Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 50 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Applying to Aydın Adnan Menderes University Application and Research Hospital, Gynecology Clinic, Gynecology Clinic,
- Coming to the examination within the first 3 months after the examination,
- Internet access,
- Having a Whatsapp or e-mail address,
- Able to read and write,
- Able to speak and understand Turkish,
- Women in the 18-50 age group are included.
Exclusion Criteria:
- Having a communication (speech, hearing, etc.) disability,
- Having any psychological illness,
- Pregnant and postpartum,
- Diagnosed with cancer,
- Women who received infertility diagnosis and treatment were excluded.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: EXPERIMENT GROUP
The trainings were held in groups of 4-6 people.
The trainings, which were held in three sessions, were held on the days and times that were convenient for the participants.
Since the participants were required to attend all sessions, additional session/sessions were held in case of not being able to attend the trainings.
Participants in the control and experimental groups were called and the day they would come for the control was determined, and they went to the gynecology outpatient clinic.
The post-test questionnaire was applied to the participants in the control and experimental groups in the first 3 months.
Until the end of the research, the participants were told that they could reach the researcher at any time and ask questions.
Finally, at the 6th month, a post-test form was applied to the participants.
|
Online education and counseling regarding gynecological examination
|
No Intervention: CONTROL GROUP
No training or counseling was given to the control group.
Participants in the control and experimental groups were called and the day they would come for the control was determined, and they went to the gynecology outpatient clinic.
The post-test questionnaire was applied to the participants in the control and experimental groups in the first 3 months.
Finally, at the 6th month, a post-test form was applied to the participants.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
A pre-test was applied to 100 women constituting the sample of the study.
Time Frame: up to 9 months.
|
Before the online training and counseling, a pre-test was applied to a total of 100 participants, 50 of which were in the experimental group and 50 in the control group.
In the pre-test question form created by the researcher in the light of the literature, sociodemographic (questions 1-9), obstetrics (questions 10-13), gynecological characteristics (questions 14-23) and attitudes towards gynecological examination (16 questions ).
|
up to 9 months.
|
The State and Trait Anxiety Inventory was applied to 100 women constituting the sample of the study.
Time Frame: up to 9 months.
|
The State and Trait Anxiety Inventory, which was developed by Spielberger (1970) and adapted to Turkish by Öner and Le Compte in 1983, was used.
The first 20 questions in the scale measure "state anxiety" and the next 20 questions measure "trait anxiety".
A score of 0-19 indicates no anxiety.
While 20-39 indicates mild anxiety, 40-59 moderate and 60-79 severe anxiety, 80 points are considered as panic.
The minimum value to be taken from the state anxiety scale is "0" and the maximum value is "80".
The minimum value to be taken from the trait anxiety scale is "0" and the maximum value is "80".
As the score increases, the level of anxiety also increases.
|
up to 9 months.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The posttest was applied to 68 people who were pretested within the first 3 months after the pretest was applied.
Time Frame: The pre-test implementation phase was completed in 9 months. This process took a total of 1 year, since the last test was applied to the last participants within the 3rd month.
|
Online training and counseling about gynecological examination was applied to the experimental group.
No counseling or training was given to the control group.
Trainings on gynecological examination were carried out in 3 sessions by determining the days and hours that women are suitable for via Google Meet.
The trainings were carried out in groups of 4-6 people.
The women in the experimental and control groups who will come for the examination were reached in advance and information was obtained about when they would come, and they went to the gynecology outpatient clinic on the day they would come for the check-up.
The post-test form was applied to the participants face to face and the form was filled by the participant himself.
The post-test form included attitude questions about gynecological examination.
|
The pre-test implementation phase was completed in 9 months. This process took a total of 1 year, since the last test was applied to the last participants within the 3rd month.
|
The State and Trait Anxiety Inventory was applied to 68 people who were pretested within the first 3 months after the pretest was applied.
Time Frame: The pre-test implementation phase was completed in 9 months. This process took a total of 1 year, since the last test was applied to the last participants within the 3rd month.
|
The State and Trait Anxiety Inventory, which was developed by Spielberger (1970) and adapted to Turkish by Öner and Le Compte in 1983, was used.
The first 20 questions in the scale measure "state anxiety" and the next 20 questions measure "trait anxiety".
A score of 0-19 indicates no anxiety.
While 20-39 indicates mild anxiety, 40-59 moderate and 60-79 severe anxiety, 80 points are considered as panic.
The minimum value to be taken from the state anxiety scale is "0" and the maximum value is "80".
The minimum value to be taken from the trait anxiety scale is "0" and the maximum value is "80".
As the score increases, the level of anxiety also increases.
|
The pre-test implementation phase was completed in 9 months. This process took a total of 1 year, since the last test was applied to the last participants within the 3rd month.
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Filling in the second post-test questionnaire online in the 6th month after both groups filled out the pre-test questionnaire.
Time Frame: Since the second posttest form was 3 months after the first posttest form (6 months after the pretest questionnaire), this process was completed in the 15th month from the beginning of the study in total.
|
Online training and counseling about gynecological examination was applied to the experimental group.
No counseling or training was given to the control group.
The post-test form was applied to the participants online.
The same questions regarding the gynecological examination included in the posttest questionnaire, which must be completed within the first 6 months after the pretest is completed.
|
Since the second posttest form was 3 months after the first posttest form (6 months after the pretest questionnaire), this process was completed in the 15th month from the beginning of the study in total.
|
The State and Trait Anxiety Inventory was administered again in the 6th month to 68 people who were posttested in the first 3 months.
Time Frame: Since the second posttest form was 3 months after the first posttest form (6 months after the pretest questionnaire), this process was completed in the 15th month from the beginning of the study in total.
|
The first 20 questions in the scale measure "state anxiety" and the next 20 questions measure "trait anxiety".
A score of 0-19 indicates no anxiety.
While 20-39 indicates mild anxiety, 40-59 moderate and 60-79 severe anxiety, 80 points are considered as panic.
The minimum value to be taken from the state anxiety scale is "0" and the maximum value is "80".
The minimum value to be taken from the trait anxiety scale is "0" and the maximum value is "80".
As the score increases, the level of anxiety also increases
|
Since the second posttest form was 3 months after the first posttest form (6 months after the pretest questionnaire), this process was completed in the 15th month from the beginning of the study in total.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: BELMA TOPTAŞ ACAR, Res.assist, belma.toptas@adu.edu.tr
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 4, 2021
Primary Completion (Actual)
March 7, 2022
Study Completion (Actual)
September 7, 2022
Study Registration Dates
First Submitted
October 2, 2022
First Submitted That Met QC Criteria
January 6, 2023
First Posted (Actual)
January 18, 2023
Study Record Updates
Last Update Posted (Actual)
January 18, 2023
Last Update Submitted That Met QC Criteria
January 6, 2023
Last Verified
January 1, 2023
More Information
Terms related to this study
Other Study ID Numbers
- BELMA TOPTAŞ ACAR
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Yes
IPD Plan Description
I have completed the data of my doctoral thesis.
There were 37 experimental groups and 31 controls who completed the study to the end.
I wrote my thesis.
After making the necessary arrangements with my advisor, I will have my thesis defense exam in December 2022.
I will share the summary of my thesis within the month after the defense.
IPD Sharing Time Frame
January 2023- December 2024
IPD Sharing Access Criteria
Klinik Çalışma Raporu (KSS)
IPD Sharing Supporting Information Type
- Clinical Study Report (CSR)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Gynecological Disease
-
Ain Shams UniversityCompletedBenign Gynecological DiseaseEgypt
-
Kangbuk Samsung HospitalRecruitingDisease (or Disorder); GynecologicalKorea, Republic of
-
The Catholic University of KoreaCompleted
-
IRCCS San RaffaeleRecruitingGynecological TumorsItaly
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.UnknownGynecological CancerChina
-
Tanta UniversityCompleted
-
Assistance Publique Hopitaux De MarseilleUnknownGynecological SurgeryFrance
-
Ain Shams Maternity HospitalUnknownGynecological PathologiesEgypt
-
Pusan National University Yangsan HospitalRecruitingGynecological SurgeryKorea, Republic of
-
Institute of Oncology LjubljanaRecruiting
Clinical Trials on Online education and counseling
-
KTO Karatay UniversityCompleted
-
Marmara UniversityCompleted
-
Seattle Children's HospitalCompletedChronic Pain | Abdominal Pain | HeadacheUnited States
-
University of ConnecticutUniversity of MalayaNot yet recruitingHIV Prevention ProgramMalaysia
-
University of ConnecticutUniversity of MalayaNot yet recruitingHIV Prevention ProgramMalaysia
-
Pamukkale UniversityRecruitingHydrocephalus in ChildrenTurkey
-
Georgetown UniversityRecruiting
-
Second Affiliated Hospital, School of Medicine,...Withdrawn
-
Medical Directions, IncUniversity of Miami; University of Arizona; Cleveland Clinic Florida; Contra Costa... and other collaboratorsCompletedMedical EducationUnited States
-
Istanbul University - Cerrahpasa (IUC)Enrolling by invitation